Trial Profile
Alpha-1 antitrypsin in COPD patients with alpha-1 antitrypsin deficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2013
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
- 04 Feb 2013 New trial record